Prevention of cataract in diabetic rats by aspirin, paracetamol (acetaminophen) and ibuprofen

Experimental Eye Research

Volumn 54, Issue 4, 1992, Pages 509-518

  Robert, Blakytny ^a   Harding, John J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

acetaminophen; acetylsalicylic acid; aspirin; blood glucose; cataract; diabetes; diabetic cataract; glucose; glutathione; glycation; glycosylation; ibuprofen; paracetamol

Indexed keywords

ACETYLSALICYLIC ACID; GLUTATHIONE; IBUPROFEN; LENS PROTEIN; PARACETAMOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATARACTOGENESIS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GLYCATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ACETAMINOPHEN; ANIMAL; ASPIRIN; BLOOD GLUCOSE; CATARACT; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; GLUTATHIONE; IBUPROFEN; LENS, CRYSTALLINE; RATS; RATS, INBRED STRAINS; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0026529770     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-4835(92)90129-G     Document Type: Article

References (30)

1. The non-enzymic glycosylation of bovine lens protein by glucosamine and its inhibition by aspirin, ibuprofen and glutathione
2. Glycosylation of nail in diabetes: possible marker of long-term hyperglycemia
3. Role of nonenzymatic glycosylation in the development of sequelae of diabetes mellitus
4. Aspirin and senile cataracts in rheumatoid arthritis
5. Aspirin prevents carbamylation of soluble lens proteins and prevents cyanate-induced phase separation opacities in vitro: a possible mechanism by which aspirin could prevent cataract
6. Evaluation of cataract-related risk factors using detailed classification systems and multivariate statistical methods
7. Free and protein-bound glutathione in normal and cataractous lenses
8. Protection against cataract by aspirin, paracetamol and ibuprofen
9. Drugs, including alcohol, that act as risk factors for cataract and a possible protection against cataract by aspirin-like analgesics and cyclopenthiazide
10. Reappraisal of hypoglycemic action of acetylsalicylate
11. Non-enzymic glycosylation (glycation) of lens proteins by galactose and protection by aspirin and reduced glutathione
12. Protein measurement using the Folin phenol reagent
13. India-US case control study of age-related cataracts
14. Nonenzymatic browning in vivo: possible process for aging of long-lived proteins
15. Nonenzymatic glycosylation, sulphydryl oxidation and aggregation of lens proteins in experimental sugar cataracts
16. Progressive changes in lens crystallin glycation and high-molecular-weight aggregate formation leading to cataract development in streptozotocin-diabetic rats
17. On the enzymatic determination of blood glucose
18. Aspirin and diabetes mellitus
19. Inhibition of glycation of albumin and haemoglobin by acetylation in vitro and in vivo
20. Ibuprofen, a putative anti-cataract drug, protects the lens against cyanate and galactose
21. Prostaglandins and diabetes
22. Statistical methods in ophthalmology: an adjustment for the intraclass correlation between eyes
23. Modelling cortical cataractogenesis: VI. Induction by glucose in vitro or in diabetic rats: prevention and reversal by glutathione
24. Is ASA therapy for cataract justified?
25. Search for a biochemical basis of diabetic microangiopathy
26. Diabetic cataract formation: potential role of glycosylation of lens crystallins
27. Inhibition of lens crystallin glycation and high molecular weight aggregate formation by aspirin in vitro and in vivo
28. Protein synthesis in the core of the calf lens
29. Lack of evidence for aspirin use and prevention of cataracts